医脉通科技有限公司（股票代码：02192）于2026年4月2日公告了截至2026年3月31日的股份变动月报表。报告显示，公司注册股本维持在50,000,000,000股，面值每股USD 0.00001，总额USD 500,000，较上月无变化。
报告期内，公司已发行股份（不包括库存股）由738,360,875股增加至738,963,750股，新增602,875股，主要来源于“首次公开发售前购股权计划（于2021年3月29日采纳）”的行使。此次行使期权共带来RMB 229,092.5的资金。与此同时，公司无购回、注销或库存股变动，亦无可换股票据等其他股份变动。
截至2026年3月末，公司已发行股份总数上升至738,963,750股，公众持股量符合上市要求。公司确认，所有股份发行及股权变动均遵守香港联交所《上市规则》及相关法律规定。
本次月报表由公司秘书签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.